AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, G.
Right arrow Articles by Tuomilehto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, G.
Right arrow Articles by Tuomilehto, J.
Agricola
Right arrow Articles by Hu, G.
Right arrow Articles by Tuomilehto, J.
American Journal of Clinical Nutrition, Vol. 86, No. 2, 457-464, August 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Coffee consumption and the incidence of antihypertensive drug treatment in Finnish men and women1,2,3

Gang Hu, Pekka Jousilahti, Aulikki Nissinen, Siamak Bidel, Riitta Antikainen and Jaakko Tuomilehto

1 From the Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute, Helsinki, Finland (GH, PJ, AN, SB, and JT); the Department of Public Health, University of Helsinki, Helsinki, Finland (GH, SB, and JT); the Tampere School of Public Health, University of Tampere, Tampere, Finland (PJ); Oulu City Hospital and Department of Internal Medicine, Oulu University, Oulu, Finland (RA); and South Ostrobothnia Central Hospital, Seinäjoki, Finland (JT)

Background: Only 2 prospective studies have previously investigated the association between coffee consumption and incident hypertension, and the findings are equivocal.

Objective: The objective was to determine the relation between coffee consumption and the incidence of antihypertensive drug treatment.

Design: We prospectively followed 24 710 Finnish subjects aged 25-64 y without a history of antihypertensive drug treatment, coronary heart disease, or stroke at baseline. Daily coffee consumption was assessed by questionnaires.

Results: During a mean follow-up period of 13.2 y, 2505 participants started antihypertensive drug treatment. The multivariate-adjusted (age, sex, study year, education, leisure-time physical activity, smoking, body mass index, high total cholesterol, history of diabetes, and alcohol, tea, fruit, vegetable, sausage, and bread consumption) hazard ratios for antihypertensive drug treatment associated with the amount of coffee consumed daily (0-1, 2-3, 4-5, 6-7, or ≥8 cups) were 1.00, 1.29 (95% CI: 1.09, 1.54), 1.26 (95% CI: 1.06, 1.49), 1.24 (95% CI: 1.04, 1.48), and 1.14 (95% CI: 0.94, 1.37) (P for trend = 0.024), respectively. This trend became marginally significant after additional adjustment for baseline systolic blood pressure (P for trend = 0.077).

Conclusions: The results indicate that coffee drinking seems to increase the risk of antihypertensive drug treatment, and this risk was higher in subjects with low-to-moderate coffee intakes; however, there was no significantly increased trend in drinkers of {approx}1 cup (100 mL)/d or ≥8 cups/d.

Key Words: Coffee drinking • antihypertensive therapy • blood pressure • hypertension • epidemiology







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition